Reply to Letters Regarding Article, “Risk of Bleeding With 2 Doses of Dabigatran Compared With Warfarin in Older and Younger Patients With Atrial Fibrillation: An Analysis of the Randomized Evaluation of Long-Term Anticoagulant Therapy (RE-LY) Trial”

Authors

Eikelboom JW; Connolly SJ; Healey JS; Yang S; Yusuf S; Wallentin L; Oldgren J; Ezekowitz M; Alings M; Kaatz S

Circulation, Vol. 125, No. 3, pp. e293–e294

Wolters Kluwer

January 24, 2012

10.1161/circulationaha.111.061721

0009-7322

Jeffrey Sean Healey

John Eikelboom

Salim Yusuf